{"abstract": "Swedish Orphan Biovitrum, which makes the ReFacto AF treatment for hemophilia for Pfizer, received a preliminary offer from an undisclosed suitor.", "web_url": "https://www.nytimes.com/2015/04/28/business/dealbook/swedish-orphan-biovitrum-deal.html", "snippet": "Swedish Orphan Biovitrum, which makes the ReFacto AF treatment for hemophilia for Pfizer, received a preliminary offer from an undisclosed suitor.", "lead_paragraph": "LONDON \u2014 The biopharmaceutical maker Swedish Orphan Biovitrum said on Monday that it had received a preliminary takeover offer from an unnamed suitor.", "print_section": "B", "print_page": "5", "source": "The New York Times", "multimedia": [], "headline": {"main": "Sobi, Swedish Maker of Drugs for Rare Diseases, Receives Takeover Bid", "kicker": null, "content_kicker": null, "print_headline": "Sobi Gets Offer", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Swedish Orphan Biovitrum AB (Sobi)", "rank": 1, "major": "N"}, {"name": "persons", "value": "Bray, Chad", "rank": 2, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 3, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 4, "major": "N"}], "pub_date": "2015-04-27T11:09:03+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By Chad Bray", "person": [{"firstname": "Chad", "middlename": null, "lastname": "Bray", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/82fd7f59-5516-5686-86da-a8553865661c", "word_count": 200, "uri": "nyt://article/82fd7f59-5516-5686-86da-a8553865661c"}